California State Teachers Retirement System (CalSTRS)
LRMR icon

California State Teachers Retirement System (CalSTRS)’s Larimar Therapeutics LRMR Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8K Sell
2,631
-361
-12% -$1.44K ﹤0.01% 2623
2025
Q4 		$11.4K Buy
2,992
+356
+14% +$1.39K ﹤0.01% 2738
2025
Q3 		$8.51K Buy
+2,636
New +$9.88K ﹤0.01% 2887
2025
Q2 		– Sell
-3,048
Closed -$6.55K – 3088
2025
Q1 		$6.55K Hold
3,048
– – ﹤0.01% 2875
2024
Q4 		$11.8K Hold
3,048
– – ﹤0.01% 2805
2024
Q3 		$20K Hold
3,048
– – ﹤0.01% 2605
2024
Q2 		$22.1K Buy
3,048
+431
+16% +$3.3K ﹤0.01% 2567
2024
Q1 		$19.9K Sell
2,617
-1,604
-38% -$12.5K ﹤0.01% 2720
2023
Q4 		$19.2K Sell
4,221
-1,438
-25% -$4.85K ﹤0.01% 2912
2023
Q3 		$22.4K Sell
5,659
-2,872
-34% -$10.9K ﹤0.01% 2964
2023
Q2 		$26.7K Buy
+8,531
New +$34.8K ﹤0.01% 3050
2019
Q2 		– Sell
-3,963
Closed -$130K – 3065
2019
Q1 		$130K Hold
3,963
– – ﹤0.01% 2863
2018
Q4 		$235K Buy
3,963
+98
+3% +$9.67K ﹤0.01% 2685
2018
Q3 		$542K Buy
3,865
+954
+33% +$116K ﹤0.01% 2411
2018
Q2 		$357K Buy
+2,911
New +$247K ﹤0.01% 2638
2017
Q2 		– Sell
-3,835
Closed -$214K – 3037
2017
Q1 		$214K Sell
3,835
-134
-3% -$6.65K ﹤0.01% 2808
2016
Q4 		$151K Hold
3,969
– – ﹤0.01% 2910
2016
Q3 		$158K Sell
3,969
-25
-0.6% -$1.14K ﹤0.01% 2908
2016
Q2 		$287K Buy
3,994
+1,009
+34% +$79.7K ﹤0.01% 2780
2016
Q1 		$239K Buy
2,985
+442
+17% +$34.9K ﹤0.01% 2755
2015
Q4 		$192K Buy
2,543
+34
+1% +$5.46K ﹤0.01% 2865
2015
Q3 		$962K Hold
2,509
– – ﹤0.01% 2012
2015
Q2 		$1.04M Buy
2,509
+1,304
+108% +$546K ﹤0.01% 2075
2015
Q1 		$573K Buy
1,205
+142
+13% +$67.4K ﹤0.01% 2365
2014
Q4 		$393K Buy
1,063
+5
+0.5% +$1.29K ﹤0.01% 2630
2014
Q3 		$250K Buy
+1,058
New +$240K ﹤0.01% 2828

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s LRMR Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Larimar Therapeutics (LRMR) stake by 12% in Q1 2026, selling an estimated $1.44K and leaving 2,631 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2623.

California State Teachers Retirement System (CalSTRS) first reported a position in LRMR in Q3 2014 and has held it in 26 quarters since. The position peaked at $1.04M in Q2 2015. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 2,631 shares of Larimar Therapeutics worth $11.8K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 361 Larimar Therapeutics shares in Q1 2026, an estimated $1.44K.
  • Larimar Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2623 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Larimar Therapeutics in Q3 2014 and has held it in 26 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Larimar Therapeutics position peaked at $1.04M in Q2 2015.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.